Bio-Rad Laboratories, Inc. is +29% over the past year while the S&P 500 is +18%: 11 points ahead of the market. 1-year return: +29% (S&P 500 +18%). vs 200-day average: +18%, a clear uptrend. RSI (14): 44, neutral. Below its 52-week high: 6.1%.

BIOBio-Rad Laboratories, Inc.

Healthcare

$366.40+29% 1Y

$366.40

$241.7152 weeks$390.31

What is the market doing?

Mixed

No clear lean: rangebound and moderately shorted.

2 neutral, 1 without data

TrendRangeboundderived · Oct 9, 2026

Choppy, but holding above its 200-day average. Price is +18% vs its 200-day average.

Short interest3.7% of sharesFINRA · Sep 15, 2026

Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 12% since the previous count, down from 5.6% of shares outstanding three months ago.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returnbetter than 71% of the market

vs 200-day avgbetter than 84% of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How BIO is trading

Bio-Rad Laboratories, Inc. is +29% over the past year while the S&P 500 is +18%: 11 points ahead of the market.

+29%

1-year return · S&P 500 +18%

vs 200-day average: +18%
vs 200-day average · a clear uptrend
RSI (14): 44
RSI (14) · neutral
Below its 52-week high: 6.1%
Below its 52-week high

Sep 18, 2024$216.56 – $390.31 · dashed line: 200-day averageOct 9, 2026

Details›

Last close2026-10-09: $366.40
1 monthS&P 500 +2.7%: −0.68%
1 yearS&P 500 +18%: +29%
5 yearsS&P 500 +88%: −54%
vs 50-day average$368.88: −0.67%
52-week high: $390.31
52-week low: $241.71
Annualised volatility: 41%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08: −$136K

Calendar-year price return
Year	Return
2026 (year to date)	+21%
2025	−7.8%
2024	+1.7%
2023	−23%
2022	−44%
2021	+30%
2020	+58%
2019	+59%
2018	−2.7%
2017	+31%

Average return by calendar month, 2016–2026
Month	Years	Positive	Average
Jan	10	5 of 10	+1.3%
Feb	10	7 of 10	−0.89%
Mar	10	5 of 10	−0.65%
Apr	10	6 of 10	+0.90%
May	10	6 of 10	+1.7%
Jun	10	6 of 10	+0.01%
Jul	11	11 of 11	+9.0%
Aug	11	6 of 11	+3.5%
Sep	11	3 of 11	−2.9%
Oct	11	4 of 11	−1.7%
Nov	10	7 of 10	+5.7%
Dec	10	6 of 10	−1.7%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.

On our screens:Stocks with no debt

Medical Devices

Ranks #22 of 51 by RyuScore